Practical Management of CD30 +Lymphoproliferative Disorders
Primary cutaneous CD30 + lymphoproliferative disorders (LPDs) account for approximately 25% of cutaneous lymphomas. Although these LPDs are clinically heterogeneous, they can be indistinguishable histologically. Lymphomatoid papulosis rarely requires systemic…